B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study - eBioMedicine
Cancers | Free Full-Text | Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions
Treatment resistance in diffuse large B-cell lymphoma | Leukemia
Prognostic significance of helicobacter pylori-infection in gastric diffuse large B-cell lymphoma | BMC Cancer | Full Text
Overall survival of patients with diffuse large B-cell lymphoma... | Download Scientific Diagram
Novel model predicts prognosis for patients with diffuse large B-cell lymphoma in first relapse after initial R-CHOP therapy: a single-institution study in China - Wei Wang, Jingjing Yin, Wei Zhang, Yan Zhang,
Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy | Annals of Hematology
Ibrutinib improves diffuse large B-cell lymphoma survival - NCI
Frontiers | Real-World Estimation of First- and Second-Line Treatments for Diffuse Large B-Cell Lymphoma Using Health Insurance Data: A Belgian Population-Based Study
The overall survival of in diffuse large B‐cell lymphoma (DLBCL)... | Download Scientific Diagram
Outcomes of Autologous Hematopoietic Cell Transplantation in Diffuse Large B Cell Lymphoma Refractory to Firstline Chemoimmunotherapy - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular ...
Diffuse Large B Cell Lymphoma - an overview | ScienceDirect Topics
A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study | Haematologica
Determining Prognosis for Patients With Diffuse Large B-Cell Lymphoma - Hematology Advisor
RELB AS A NOVEL PROGNOSTIC BIOMARKER FOR DIFFUSE LARGE B-CELL LYMPHOMA ( DLBCL) | ERGANEO
Disease-free survival of patients with diffuse large B-cell lymphoma... | Download Scientific Diagram
A: Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System - The ASCO Post
Patient Information: Diffuse Large B Cell Lymphoma
Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study | Anticancer Research
A: Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System - The ASCO Post
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
Diffuse Large B-Cell Lymphoma | NEJM
About RITUXAN® (rituximab) | Diffuse Large B Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL): Symptoms, Treatment and Prognosis – Nova Science Publishers
